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Abstract:  Introduction: In patients with carotid artery stenosis histological plaque composition is associated with 
plaque  stability and with presenting symptomatology. Preferentially, plaque vulnerability  should be taken into ac-
count in pre-operative work-up of patients with severe carotid artery stenosis. However, currently no appropriate and 
conclusive (non-) invasive technique to differentiate between the high and low risk carotid artery plaque in vivo is
available. We propose that 7 Tesla human high resolution MRI scanning will visualize carotid plaque characteristics 
more precisely and will enable correlation of these specific components with cerebral damage. 
Study objective: The aim of the PlaCD-7T study is 1: to correlate 7T imaging with carotid plaque histology (gold 
standard);  and 2:  to correlate  plaque characteristics  with cerebral  damage ((clinically silent) cerebral (micro) infarcts 
or bleeds) on 7 Tesla high resolution (HR) MRI. 
Design: We propose a single center prospective study for either symptomatic or asymptomatic patients with 
haemodynamic significant (70%) stenosis of at least one of the carotid arteries. The Athero-Express (AE) biobank 
histological analysis will be derived according to standard protocol. Patients included in the AE and our prospec-
tive study will undergo a pre-operative 7 Tesla HR-MRI scan of both the head and neck area. 
Discussion: We hypothesize that the 7 Tesla MRI scanner will allow early identification of high risk carotid plaques 
being associated with micro infarcted cerebral areas, and will thus be able to identify patients with a high risk of peri-
procedural stroke, by identification of surrogate measures of increased cardiovascular risk. 
Keywords: 7 Tesla MRI, carotid plaque, cerebral damage, histology. 
INTRODUCTION 
  Ipsilateral carotid stenosis of 50% or more is found in 
approximately 10% of carotid territory ischemic strokes and 
approximately 15% of transient ischemic attacks (TIAs). 
Additionally, it is associated with a high risk of recurrent 
stroke [1, 2]. Current treatment of symptomatic patients with 
carotid stenosis is based on stenosis grade alone, where 
stenosis >70% indicates carotid endarterectomy (CEA). 
Plaque morphology is not yet included in this clinical deci- 
sion, although it plays an important role as it is found to be 
directly correlated with the risk of embolism and progression 
to occlusion, thus resulting in cerebral ischaemia [3]. 
Thrombo-embolic events, caused by (a) (ruptured) athero- 
sclerotic carotid plaque(s), can cause a TIA or ischemic 
stroke. Carotid plaque phenotype is a major independent 
determinant of the clinical outcome after CEA, while plaque 
composition is related to clinical presentation, gender, age 
and time interval between most ischemic symptoms and 
CEA [4-9]. 
  Athero-Express [10] (AE; plaque biobank) studies have 
previously shown that certain compositions of the athero- 
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sclerotic plaque are associated with pre- and postoperative 
cerebral embolisation measured with Trans Cranial Doppler 
(TCD). Clinically, patients with a more inflamed plaque 
showed more embolisation [11], and the composition of the 
atherosclerotic plaque was associated with repeated cerebral 
infarcts after surgery [12]. In addition, patients with a fi- 
brotic plaque had a lower risk for recurrent TIA or stroke 
than patients with a more lipid-rich plaque [3]. In the same 
study, during three years follow-up, it was found that a high 
rate of neovasculature with intra-plaque haemorrhage (IPH) 
was a strong predictor for cardiovascular events elsewhere in 
the vascular tree. Thus, the classically defined measures for 
plaque vulnerability (plaque bleeding, large lipid cores and 
local inflammation) were all related with adverse outcomes 
peri-operatively as well as during follow up. 
  Important intra-plaque markers for plaque stability are 
the relative amounts of smooth muscle cells (SMC) and col-
lagen. Hellings et al. showed that women have more stable 
plaques compared to men, with specifically more stable 
plaques in asymptomatic women. These stable plaques were 
fibrotic and had a relatively higher SMC and collagen con-
tent [5]. 
  Identification of high-risk patients, preferably with 
minimally invasive techniques such as MRI, could lead to 
different peri- and postoperative monitoring of CEA patients. 
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the stenotic carotid artery. Several preliminary studies, both 
ex vivo and in vivo, have been performed to assess the possi- 
bility of plaque imaging with MRI [13-20]. 
  Ultimately we aim that high resolution (HR) 7 Tesla di-
agnostic accuracy will be valuable in clinical decision mak-
ing by differentiating low risk and high risk patients and 
thereby determining which patients benefit most from revas-
cularization. This prognostic study could ultimately lead to 
the addition of a 7 Tesla HR-MRI scan to differentiate low 
risk and high risk patients. 
Ex Vivo MRI Plaque Studies 
 In  an  ex vivo study using dissected human carotid arter-
ies (autopsy material), plaque components were evaluated 
using  different HR-MRI weightings at 9.4 Tesla  (vertical 
Bruker system). The outcome of this study suggested that 
HR-MRI is able to visualize several plaque characteristics, 
which were previously related with increased embolisation 
and repeated stroke. Multi-weighted MRI sequences could 
identify calcified regions, lipid area, foam cell area, IPH, 
neovasculature and the  fibrous  cap (submitted data;  te 
Boekhorst et al.). Although this study was performed on 
autopsy material (no flow effects of blood) and at a high 
magnetic field, it gives information about which compo-
nents could be visualized with the 7 Tesla human MRI 
scanner, whereas this might be more challenging if not 
impossible in a lower field MRI scanner. Several other ex 
vivo  studies on human MRI scanners (1.5 Tesla) have 
been performed on atherosclerotic plaques obtained from 
CEA [13, 14]. Both studies found sensitivity values  rang-
ing from 60-97%  to 72-98% for  fibrous tissue,  necrosis, 
calcification and for loose connective tissue. Specificity 
varied from 75%-98% to 74%-99% for the same plaque 
characteristics. 
In Vivo MRI Plaque Studies 
 Several  human  in vivo studies investigated 1.5 and 3 
Tesla MRI as a tool to accurately determine plaque com-
ponents, sometimes with histology as a reference [15-20]. 
For example, one study revealed sensitivity and specificity 
of 84%, a negative predictive value of 70%, and a positive 
predictive value of 93% of direct thrombus imaging with 
MRI, with histology as the gold standard. This would 
suggest that MRI can accurately determine plaque com-
ponents with an 1.5 Tesla MRI scanner [17]. However, 
these studies merit careful consideration. The resolution 
of the 1.5 Tesla scanner is very limited and although the 3 
Tesla scanner already has a higher resolution, for example 
imaging of large IPH and thin/ruptured fibrous cap is pos-
sible [17], moderate IPH is difficult to detect. In addition, 
up to now it has not been possible to discriminate be-
tween IPH and intra-plaque lipid. The latter is of great 
interest since recent studies have shown that IPH and not 
intra-plaque lipid is related with adverse events during fol-
low up [3]. 
  In summary, we believe due to the limitations of the 
above reported study methods and lower resolution of the 
current MRI scanners, it is valuable to perform an in vivo
study with the 7 Tesla scanner to optimize the relevance of 
plaque characterization. In the present article we describe the 
protocol of our study designed to determine the relation be-
tween carotid plaque characteristics and cerebral damage by 
7 Tesla HR-MRI. To our knowledge this is the first study 
that investigates this relation with a 7 Tesla MRI scanner. 
STUDY OBJECTIVE 
  We plan to conduct a single center, prospective, observa- 
tional study, using a 7 Tesla MRI scanner (Philips 
Healthcare, Cleveland, OH, USA). The primary objective of 
PlaCD-7T (atherosclerotic carotid PLAque components 
correlated with Cerebral Damage at 7 Tesla) is to compare 
7T HR-imaging with carotid plaque histology (gold stan-
dard). Our secondary objective is to correlate plaque charac-
teristics with cerebral damage ((clinically silent) cerebral 
(micro) infarcts or bleeds) on 7 Tesla HR-MRI. 
  Histology will be performed to compare the ex vivo
specimen with the in vivo images. Only one pre-operative 
HR-MRI scan will be added to the standard work-up of CEA 
patients in our hospital. 
MRI 7.0 Tesla Scanner 
  7 Tesla MRI benefits from a high intrinsic Signal-to- 
Noise Ratio (SNR) compared to MRI with lower field 
strengths. The gain in SNR can be expressed in shorter scan 
times as well as higher resolution. Above that, different con-
trast mechanisms due to changed magnetic parameters in the 
tissues may lead to higher sensitivities for certain contrasts. 
For example, susceptibility differences are greater at 7 Tesla 
as well as the differences in chemical shift and relaxation 
times between different tissues. Also, higher resolution im-
aging suffers less from partial voluming effects, enabling the 
visualization of more detailed structures. More and more 
research is being done to explore this potential of 7 Tesla 
MRI [21, 22]. High field MR (plaque) imaging with 7 Tesla 
may allow plaque characterization and localization of cere- 
bral damage with a higher resolution and more detail than 
imaging at lower field strengths. For instance, not only obvi- 
ous cerebral ischemic lesions can be found, but also micro- 
bleeds, micro-infarcts and clinically silent ischemic lesions 
can be visualized, currently not possible with 1.5 Tesla or 3 
Tesla MRI [22] (Fig. 2). 
  The main reason for imaging patients scheduled for CEA 
at 7 Tesla is the high resolution and high contrast brain scan. 
Since we would like to correlate cerebral damage to specific 
plaque components it is of importance to have superior im- 
age quality of the brain. At the moment a few human studies 
at 7 Tesla have successfully been performed and published 
[23-26]. In addition, hypothetically, plaque imaging with 7 
Tesla MRI could provide more detailed images of the plaque 
components. The 1.5 and 3 Tesla MRI may lack some dis- 
criminative power to assess plaque characteristics that corre- 
late with risk for future manifestations of the disease. How- 
ever, even if 7 Tesla MRI is not capable of discriminating 
more components in plaque compared to 3 Tesla MRI, the 
addition of the 7 Tesla brain imaging will provide new in- 
sights into the pathogenesis of cerebral damage as a result of 
plaque composition. Apart from these new insights, when 
this study shows that micro-infarctions, micro-embolisations 
or plaque characteristics can be visualized with these 7 Tesla 
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establish the value of non-invasive MRI scanning in pre- 
operative work-up in patients with carotid artery stenosis. 
STUDY DESIGN 
  This is an observational study. First of all, patients with a 
stenosis >70% of the carotid artery will visit the vascular 
surgeon or neurologist in our hospital. Subsequently these 
patients are discussed in our multidisciplinary vascular meet- 
ing (vascular surgeons, neurologists, radiologists). When 
eligible for CEA, the patient will be included via the vascu-
lar surgeon in the AE study as well as the PlaCD-7T study. 
The majority of the patients will be symptomatic (TIA or 
stroke). However, a minority of asymptomatic patients with 
a haemodynamically significant stenosis >80% of the carotid 
artery and planned to be scheduled for a CEA will be eligible 
for inclusion in this study as well. Pre-operative (~1 day) the 
included patients are scheduled for a MRI scan of the brain 
and carotid artery in the 7 Tesla MRI scanner. Anatomical 
scans of the brain will be evaluated for the presence of cere- 
bral damage. In the carotid artery, MRI images with several 
contrast weightings will be acquired for plaque visualization 
and characterization. A contrast agent (gadolinium (Gado- 
vist®)) will be injected to assess neovascularisation, intra- 
plaque haemorrhage and inflammation. This investigation 
will take approximately 75 minutes [27]. Images will be 
stored and during off line analyses the bifurcation of the ca-
rotid artery will be used as an anatomical landmark. 
Patient Population 
  All indications for surgery are reviewed by a multidisci- 
plinary vascular team [10]. All patients are examined by a 
neurologist pre-operatively and postoperatively to document 
cerebrovascular symptom status and to record any new neu- 
rological deficits after CEA. Percentage stenosis of both ca-
rotid arteries is recorded with duplex ultrasound pre-
operatively following internationally accepted guidelines 
[28]. A flowchart of the study protocol is shown in Fig. (1). 
Baseline characteristics of included patients will be collected 
by the AE investigators and include standard baseline char- 
acteristics together with known risk factors of cardiovascular 
disease. It is important to state that besides one MRI scan, 
patients will have the regular work-up, treatment, and   
follow-up according to the current guidelines for treatment 
of carotid artery disease. 
Athero-Express Biobank 
  AE is an ongoing longitudinal study that includes pa-
tients undergoing CEA. The study design has been reported 
earlier [10]. In our study gold standard for plaque characteri-
zation will be the histopathological analysis of the removed 
Fig. (1). Simplified flowchart of study protocol. 
Analysis of all results 
Inclusion in Athero-Express (AE) study 
30 Patients participating in PlaCD-7T  Patients not participating in PlaCD-7T 
Inclusion in PlaCD-7T 
30 patients pre-operative 7T MRI (75 minutes) with:  
 Plaque  imaging 
 Brain scans 
CEA (mostly on Thursdays) 
 Peri-operative  TCD 
 Plaque  removal   histology 
Patients eligible for CEA (symptomatic & asymptomatic) 
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carotid artery plaque according to the standardized AE pro-
tocol. The segment with the largest plaque burden (the cul-
prit lesion) is located and fixated in formalin for histological 
analysis. This analysis is routinely performed and intra- and 
inter-observer analyses are excellent and have been reported 
in international literature previously [27]. After surgery, the 
patients undergo normal clinical follow-up with duplex to 
assess procedural restenosis and to fill out questionnaires 
addressing the occurrence of relevant cardiovascular symp-
toms. All patients undergoing CEA in one participating cen-
ter (University Medical Center Utrecht) will be asked to par-
ticipate in this study. The medical ethics board of the Uni-
versity Medical Center Utrecht approved the study, and all 
participants of this study must provide written informed con-
sent. 
Scan Protocol 
  The total MRI examination including MR plaque imag- 
ing and anatomical MRI of the brain will take approximately 
75 minutes (Fig. 3). A dedicated RF coil is used for imaging 
of the carotid bifurcation. This coil allows for sub-millimeter 
resolution imaging of the carotid lumen, vessel wall and 
atherosclerotic plaque. First, the carotid bifurcation is identi-
fied by means of MR angiography without contrast   
enhancement. Subsequently, several transverse images are 
obtained from several millimeters caudal to several   
millimeters cranial of the carotid bifurcation, imaging the 
complete plaque. This area is imaged using specific   
sequences to obtain different contrast weightings for optimal 
discrimination of plaque components. Next, post-contrast 
images after intravenous injection of gadolinium will be   
obtained. Additionally, anatomical MR brain imaging of 
cerebral damage will be performed. For example, 3D 
FLAIR, T1W, SWI (susceptibility weighted imaging) and 
DWI (diffusion weighted imaging) images can be acquired 
using the head coil. Two MRI readers blinded to the   
histo-pathological results and clinical data will independ-
ently score the MRI plaque status. 
Carotid Endarterectomy 
  Pre-operatively, patients start with aspirin, except those 
patients already taking oral anticoagulants for other indica- 
tions. For these patients dipyridamol 2dd200mg will be 
added. Patients with aspirin intolerance will receive plavix 
75mg. Before exposure of the carotid artery, patients receive 
5000 U of heparin intravenously. With the use of a standard- 
ized CEA technique, the plaque is carefully dissected and 
removed in toto, without procedure-related complications. 
Immediately after dissection, the plaque will be transferred 
to the laboratory. 
Histology 
  The atherosclerotic plaque will be decalcified in an 
EDTA solution, sliced at several loci, embedded in paraffin, 
and stained for presence of collagen (picrosirius red), macro- 
phages (CD68), smooth muscle cells (-actin), lipid, throm- 
bus and endothelium (CD34, microvessels or neovascula- 
ture). This analysis is routinely performed and intra- and 
inter-observer analyses are excellent and have been reported 
in international literature previously [27]. Histology is as- 
sessed by an experienced pathologist blinded to the MRI 
results. 
Sample Size 
  In a previous study we observed a >100% increase in 
peri-operative stroke when a lipid rich plaque was obtained 
compared to plaques that were fibrous [3]. A major endpoint 
was reached in 9% when a lipid rich lesion was evident but 
2.5% when a fibrous lesion was present. We expect to see 
significantly more cerebral micro-infarcted areas (33% of 
patients). This data is based on the article of Verhoeven, et al
[11]. In this study TCD was used to measure micro embo- 
lism. In 27% of the patients an event was registered before or 
during surgery. We expect the 7 Tesla system to be sensitive 
enough to find micro infarcts as a result of micro embolism. 
The power analysis is based on the calculation of the differ- 
ences between two groups of a continuous variable. A 3-fold 
increase from 1 to 3 micro embolisms or 1 versus 3 micro 
infarcts with an SD of 2, an   of 0.05 and   of 0.80 we calcu- 
late that we will need 2 groups of 14 patients. Therefore we 
asked and received permission to include 30 patients. We do 
not expect a normal distribution. 
Data Analysis 
  MR images will be processed with dedicated software, 
with this software component size and intensity on images 
will be calculated. Histology will be semi-quantitatively 
scored as previously described [3, 10]. Cerebral damage 
((clinically silent) cerebral (micro) infarcts or bleeds) will be 
depicted as a semi-quantitative measure (no, small, major 
defects). Micro-embolisation will be assessed as a continu- 
ous variable. 
  The different identified plaque components will be corre- 
lated with cerebral damage by calculating the regular pa- 
rameters for diagnostic testing (positive predictive value, 
negative predictive value, sensitivity, specificity). 
Ethical Consideration 
This study has been approved by the local Medical Ethical 
Committee of the University Medical Center of Utrecht. 
DISCUSSION 
  We present the protocol of a single center, observational 
study to determine the relation of plaque characteristics with 
cerebral damage ((clinically silent) cerebral (micro) infarcts 
or bleeds) with 7 Tesla HR-MRI. As gold standard histology 
of the plaques will be obtained according to the protocol of 
the AE biobank. 
  The interpretation of outcome in earlier studies imaging 
the carotid plaque and using histology as reference standard 
is complicated by the differences in histology methods, dif- 
ference in the magnetic field strength of the MRI scanners 
and in scanning protocols (sequences). 
 In  summary: 
 Characteristics  ex vivo studies: 
-   No blood flow, thus no triggering is needed and no flow 
artifacts are seen. Additionally, artifacts caused by swallow- 
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Fig. (2). Imaging examples of the carotid artery on 7  Tesla 
MRI, acquired with a 4 channel tranceive coil (Machnet B.V., 
Eelde, The Netherlands). 
-   The RF coil is placed very close to the plaque, creating 
higher signal intensities compared to in vivo measurements. 
 Limitations  ex vivo studies: 
  Outcome can not always be extrapolated to the realistic 
in vivo measurements. 
 Limitations  current  in vivo studies: 
- 1.5 Tesla and 3 Tesla scanners; lower resolution scanners  
- not possible to discriminate between IPH and intra- 
plaque lipid  
- in vivo, the length of the neck and depth of the carotid 
artery are main determinants of image quality. Some se- 
quences, which can give excellent contrast between   
components ex vivo, are not applicable in vivo, due to tim-
ing of the sequence or due to limited total scan time of the 
patient. 
-  different histology protocols 
Fig. (3). Procedural set-up in 7 Tesla scanner. 
  Advantages 7 Tesla MRI scanner: 
-   advanced brain imaging 
-   Higher resolution will reveal structures that are hidden by 
partial voluming and higher sensitivity for certain 
contrastmechanisms (e.g. susceptibility weighted imaging 
or Ultra short TE imaging (UTE)) will possibly allow 
detection of plaque components that are hard to detect 
with lower field strengths, like IPH). 
  Several studies have focused on the identification of 
atherosclerotic plaque components by means of MRI to iden- 
tify patients at risk for strokes or TIAs [15-20]. Components 
such as large lipid pools, thin fibrous caps, and IPH are the 
main focus points due to the increased risk of plaque rupture. 
One of the components that is of importance and has been 
correlated with cardiovascular and cerebrovascular events is 
microvasculature in the plaque [3]. However, this component 
is very small (the same holds true for mild/moderate IPH) 
and needs an imaging modality with a high spatial resolution 
and anatomical detail such as the 7 Tesla scanner can pro-
vide. In addition, the 7 Tesla scanner is superior in the detec-
tion of micro-infacts and/or bleeds in the brain [26]. Com-
bining this information with the HR-MRI of the atheroscle-
rotic plaque, as described in this protocol, we believe this 
can give new insights and possibly lead to new standardized 
protocols for patient work-up before CEA. 
  In conclusion, we hypothesize that 7 Tesla HR-MRI will 
allow more detailed visualization of the brain, and is ex- 
pected to determine the carotid plaque components more 
precisely. Therefore, in our opinion, this is the right modality 
to correlate brain imaging with carotid plaque characteristics. 
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reference according to standardized Athero-Express proto- 
col. 
  The trial will start in March 2011 in the University Medi-
cal Center in Utrecht. 
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ABBREVIATIONS 
CEA =  Carotid  endarterectomy 
HR   =  High  resolution 
AE   =  Athero-express 
DWI =  Diffusion  weighted  imaging 
IPH =  Intra-plaque  haemorrhage 
FLAIR  =  Fluid attenuation inversion recovery 
MRI  =  Magnetic resonance imaging 
RF =  Radio  frequency 
SMC =  Smooth  muscle  cells 
SWI  =  Susceptibility weighted imaging 
T1W =  T1  weighted 
TCD =  Trans  Cranial  Doppler 
CONFLICT OF INTEREST 
 None  declared. 
ACKNOWLEDGMENTS 
  S.M. Bovens’ work was funded by the Netherlands Heart 
Foundation (2006T106 to SB). 
REFERENCES 
[1]  Lovett JK, Coull AJ, Rothwell PM. Early risk of  recurrence 
by subtype of ischemic stroke in  population-based incidence 
studies. Neurology 2004; 62(4): 569-73. 
[2]  Fairhead JF, Mehta Z, Rothwell PM.  Population-based study of 
delays in carotid  imaging  and surgery and the risk of recurrent 
stroke. Neurology 2005; 65(3): 371-5. 
[3]  Hellings WE, Peeters W, Moll FL, et al. Composition of ca-
rotid atherosclerotic plaque is associated with cardiovascular out-
come: a prognostic study. Circulation 2010; 121(17): 1941-50. 
[4]  Carr S, Farb A, Pearce WH, Virmani R, Yao JS. Atheroscle-
rotic plaque rupture in symptomatic carotid artery stenosis. J Vasc 
Surg 1996; 23(5): 755-65.
[5]  Hellings WE, Pasterkamp G, Verhoeven BA, et al. Gender- associ-
ated differences in plaque phenotype of patients undergoing ca-
rotid endarterectomy. J Vasc Surg 2007; 45(2): 289-96. 
[6]  Peeters W, Hellings WE, de Kleijn DP, et al. Carotid  athero-
sclerotic plaques stabilize after stroke: insights into the natural 
process of atherosclerotic plaque stabilization. Arterioscler Thromb 
Vasc Biol 2009; 29(1): 128-33. 
[7]  Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM. Histological 
assessment of 526 symptomatic carotid plaques in relation to 
the nature and timing of ischemic symptoms: the Oxford plaque 
study. Circulation 2006; 113(19): 2320-8. 
[8]  van Oostrom O, Velema E, Schoneveld AH, et al. Age-related
changes in plaque composition: a study in patients suffering from 
carotid artery stenosis. Cardiovasc Pathol 2005; 14(3): 126-34. 
[9]  Verhoeven B, Hellings WE, Moll FL, et al. Carotid atherosclerotic 
plaques in patients with transient ischemic attacks and stroke have 
unstable characteristics compared  with plaques in asymptomatic 
and amaurosis fugax patients. J Vasc Surg 2005; 42(6): 1075-81. 
[10]  Verhoeven BA, Velema E, Schoneveld AH, et al. Athero-express: 
differential atherosclerotic plaque expression of mRNA and protein 
in relation to cardiovascular events and patient characteristics. Ra- 
tionale and design. Eur J Epidemiol 2004; 19(12): 1127-33. 
[11]  Verhoeven BA, de Vries JP, Pasterkamp G, et al. Carotid athero- 
sclerotic plaque characteristics are associated with microemboliza- 
tion during carotid endarterectomy and procedural outcome. Stroke 
2005; 36(8): 1735-40. 
[12]  Verhoeven BA, Pasterkamp G, de Vries JP, et al. Closure of 
the  arteriotomy after carotid  endarterectomy: patch type is re-
lated to intraoperative microemboli and restenosis rate. J Vasc 
Surg 2005; 42(6): 1082-8. 
[13]  Clarke SE, Hammond RR, Mitchell JR, Rutt BK. Quantitative 
assessment of carotid plaque composition using multicontrast MRI 
and registered histology. Magn Reson Med 2003; 50(6): 1199-208. 
[14]  Fabiano S, Mancino S, Stefanini M, et al. High-resolution 
multi- contrast-weighted MR imaging from human carotid endarter-
ectomy specimens to assess carotid plaque components. Eur Radiol 
2008; 18(12): 2912-21. 
[15]  Alizadeh DR, Doornbos J, Tamsma JT, et al. Assessment of 
the carotid artery by MRI at 3T: a study on reproducibility. J Magn 
Reson Imaging 2007; 25(5): 1035-43. 
[16]  Kerwin W, Xu D, Liu F, et al. Magnetic resonance  imaging 
of carotid atherosclerosis: plaque analysis. Top Magn Reson Im-
aging 2007; 18(5): 371-8. 
[17]  Ota H, Yu W, Underhill HR, et al. Hemorrhage and large lipid-rich 
necrotic cores are independently  associated with thin or rup-
tured fibrous caps: an in vivo 3T MRI study. Arterioscler Thromb 
Vasc Biol 2009; 29(10): 1696-701. 
[18]  Moody AR, Murphy RE, Morgan PS, et al. Characterization of 
complicated carotid plaque with magnetic resonance direct throm- 
bus imaging in patients with cerebral  ischemia. Circulation 
2003 24; 107(24): 3047-52. 
[19]  Cappendijk VC, Cleutjens KB, Kessels AG, et al. Assessment 
of human atherosclerotic carotid plaque components with multise- 
quence MR  imaging: initial experience. Radiology 2005; 234(2): 
 487-92.
[20]  Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high 
resolution MRI for atherosclerotic carotid artery tissue characteri- 
zation. J Magn Reson Imaging 2002; 15(1): 62-7. 
[21]  Snyder CJ, DelaBarre L, Metzger GJ, et al. Initial results of cardiac 
imaging at 7 Tesla. Magn Reson Med 2009; 61(3): 517-24. 
[22]  Zwanenburg JJ, Hendrikse J, Visser F, Takahara T, Luijten 
PR.  Fluid attenuated inversion recovery (FLAIR) MRI  at  7.0 
Tesla: comparison with 1.5 and 3.0 Tesla. Eur Radiol 2010; 20(4): 
915-22. 
[23]  Pfeuffer J, Adriany G,  Shmuel A, et  al. Perfusion-based  high- 
resolution functional imaging in the human brain at 7 Tesla. Magn 
Reson Med 2002; 47(5): 903-11. 34    Current Cardiology Reviews, 2011, Vol. 7, No. 1  den Hartog et al. 
[24]  Yacoub E, Shmuel A, Pfeuffer J, et al. Imaging brain function in 
humans at 7 Tesla. Magn Reson Med 2001; 45(4): 588-94. 
[25]  Vaughan JT, Garwood M, Collins CM, et al. 7T vs. 4T: RF power, 
homogeneity, and signal-to-noise comparison in head images. 
Magn Reson Med 2001; 46(1): 24-30. 
[26]  Pfeuffer J, Van De Moortele PF, Yacoub E, et al. Zoomed 
functional imaging in the human brain at  7 Tesla with simul-
taneous high spatial and high temporal resolution. Neuroimage 
2002; 17(1):272-86. 
[27]  Hellings WE, Pasterkamp G, Vollebregt A, et al. Intraobserver and 
interobserver variability and spatial  differences in histologic ex-
amination of carotid endarterectomy specimens. J Vasc Surg 2007; 
46(6): 1147-54. 
[28]  Grant EG, Benson CB, Moneta GL, et al. Carotid artery stenosis: 
gray-scale and Doppler US diagnosis--Society of Radiologists in 
Ultrasound Consensus Conference. Radiology 2003; 229(2): 340-6. 
Received: October 16, 2010  Revised: October 16, 2010         Accepted: January 7, 2011 